HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation-Reference-Cited by-同舟云学术

HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation

Published:2019-09 Issue: Volume:117 Page:109121
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Duan Tao,Xu Zhuobin,Sun Fumou,Wang Yang,Zhang Juan,Luo Chen,Wang Min

Funder

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Double First-Class University Project

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference50 articles.

1. Triple-negative breast cancer and the potential for targeted therapy;Jhan;Pharmacogenomics,2017

2. An overview of triple negative breast cancer for surgical oncologists;Sharma;Surg. Oncol.,2015

3. Subtyping of triple-negative breast cancer: implications for therapy;Abramson;Cancer,2015

4. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat. Rev. Clin. Oncol.,2016

5. New horizons in tumor microenvironment biology: challenges and opportunities;Chen;BMC Med.,2015

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives;International Journal of Pharmaceutics;2024-10

2. Advances in tumor stroma-based targeted delivery;International Journal of Pharmaceutics;2024-10

3. Recent Progress of Multifunctional Molecular Probes for Triple-Negative Breast Cancer Theranostics;Pharmaceutics;2024-06-14

4. Aptamers for the Delivery of Plant-Based Compounds: A Review;Pharmaceutics;2024-04-14

5. Clinical Advances in Triple Negative Breast Cancer Treatment: Focus on Poly (L-lactide-coglycolide) Nanoparticles;Journal of Pharmacology and Experimental Therapeutics;2024-04-05